Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,341 | 15 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $381.81 | 4 | $0 (2023) |
| ABBVIE INC. | $263.92 | 3 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $186.36 | 2 | $0 (2023) |
| HeartFlow, Inc. | $117.06 | 1 | $0 (2022) |
| Biohaven Pharmaceutical Holding Company Ltd. | $115.24 | 1 | $0 (2022) |
| Esperion Therapeutics, Inc. | $105.84 | 1 | $0 (2021) |
| Genentech USA, Inc. | $76.63 | 1 | $0 (2021) |
| Insmed, Inc. | $76.23 | 1 | $0 (2022) |
| Nestle HealthCare Nutrition Inc. | $18.17 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $466.39 | 5 | Novo Nordisk Inc ($199.93) |
| 2022 | $571.31 | 6 | Novo Nordisk Inc ($181.88) |
| 2021 | $303.56 | 4 | Esperion Therapeutics, Inc. ($105.84) |
All Payment Transactions
15 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/06/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $83.44 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/02/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $98.77 | General |
| Category: Obesity | ||||||
| 04/04/2023 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $101.16 | General |
| 03/07/2023 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $99.67 | General |
| Category: NEUROSCIENCE | ||||||
| 02/07/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $83.35 | General |
| Category: NEUROSCIENCE | ||||||
| 10/04/2022 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $95.07 | General |
| Category: Obesity | ||||||
| 09/13/2022 | HeartFlow, Inc. | FFRct (Device) | Food and Beverage | Cash or cash equivalent | $117.06 | General |
| Category: Coronary | ||||||
| 06/07/2022 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $86.81 | General |
| Category: Diabetes | ||||||
| 05/13/2022 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $76.23 | General |
| Category: Respiratory | ||||||
| 03/01/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $115.24 | General |
| Category: PRIMARY CARE | ||||||
| 02/01/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $80.90 | General |
| Category: NEUROSCIENCE | ||||||
| 12/07/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $102.92 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/03/2021 | Nestle HealthCare Nutrition Inc. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $18.17 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 10/05/2021 | Genentech USA, Inc. | Esbriet (Biological) | Food and Beverage | In-kind items and services | $76.63 | General |
| Category: Immunology | ||||||
| 07/13/2021 | Esperion Therapeutics, Inc. | NEXLIZET (Drug), NEXLETOL | Food and Beverage | In-kind items and services | $105.84 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
About Kaleb Carter
Kaleb Carter is a Family healthcare provider based in Claymont, Delaware. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/14/2014. The National Provider Identifier (NPI) number assigned to this provider is 1538565726.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Kaleb Carter has received a total of $1,341 in payments from pharmaceutical and medical device companies, with $466.39 received in 2023. These payments were reported across 15 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($1,341).
Practice Information
- Specialty Family
- Other Specialties Family
- Location Claymont, DE
- Active Since 11/14/2014
- Last Updated 03/17/2025
- Taxonomy Code 363LF0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1538565726
Products in Payments
- FARXIGA (Drug) $186.36
- FFRct (Device) $117.06
- NURTEC ODT (Drug) $115.24
- NEXLIZET (Drug) $105.84
- QULIPTA (Drug) $99.67
- Wegovy (Drug) $98.77
- Saxenda (Drug) $95.07
- Rybelsus (Drug) $86.81
- VRAYLAR (Drug) $83.35
- UBRELVY (Drug) $80.90
- Esbriet (Biological) $76.63
- Arikayce (Drug) $76.23
- ZENPEP (Drug) $18.17
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.